ENTRY       D02076                      Drug
NAME        Brimonidine tartrate (JAN/USAN);
            Alphagan (TN)
PRODUCT     ALPHAGAN P (Allergan)
            BRIMONIDINE TARTRATE (Bryant Ranch Prepack)
            BRIMONIDINE TARTRATE (Sandoz)
            MIRVASO (Galderma Laboratories)
  GENERIC   BRIMONIDINE (Akorn)
            BRIMONIDINE (Bryant Ranch Prepack)
            BRIMONIDINE (Padagis Israel Pharmaceuticals)
            BRIMONIDINE TARTRATE (A-S Medication Solutions)
            BRIMONIDINE TARTRATE (Alembic Pharmaceuticals Limited)
            BRIMONIDINE TARTRATE (Alembic Pharmaceuticals)
            BRIMONIDINE TARTRATE (Apotex Corp.)
            BRIMONIDINE TARTRATE (Apotex Corp.)
            BRIMONIDINE TARTRATE (Bausch & Lomb Incorporated)
            BRIMONIDINE TARTRATE (Florida Pharmaceutical Products)
            BRIMONIDINE TARTRATE (Indoco Remedies Limited)
            BRIMONIDINE TARTRATE (Pacific Pharma)
            BRIMONIDINE TARTRATE (Sandoz)
            BRIMONIDINE TARTRATE (Somerset Therapeutics)
            BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% (Alembic Pharmaceuticals Limited)
            BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% (Alembic Pharmaceuticals)
FORMULA     C11H10BrN5. C4H6O6
EXACT_MASS  441.0284
MOL_WEIGHT  442.2214
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
              DG01450  alpha-Adrenergic receptor agonist
               DG01449  alpha2-Adrenergic receptor agonist
            Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
REMARK      Therapeutic category: 1319
            ATC code: D11AX21 S01EA05 S01GA07
            Chemical structure group: DG00442
            Product (DG00442): D02076<JP/US>
            Product (mixture): D10298<JP/US> D10854<JP/US> D12437<JP>
EFFICACY    Antiglaucoma, alpha-Adrenergic receptor agonist
  DISEASE   Open-angle glaucoma [DS:H00612]
COMMENT     Clonidine derivative
TARGET      ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
  PATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AX Other dermatologicals
                 D11AX21 Brimonidine
                  D02076  Brimonidine tartrate (JAN/USAN) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EA Sympathomimetics in glaucoma therapy
                 S01EA05 Brimonidine
                  D02076  Brimonidine tartrate (JAN/USAN) &lt;JP/US&gt;
               S01G DECONGESTANTS AND ANTIALLERGICS
                S01GA Sympathomimetics used as decongestants
                 S01GA07 Brimonidine
                  D02076  Brimonidine tartrate (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Acne and Rosacea Agents
               Acne and Rosacea Agents, Other
                Brimonidine
                 D02076  Brimonidine tartrate (JAN/USAN)
             Ophthalmic Agents
              Intraocular Pressure Lowering Agents
               Alpha-adrenergic Agonists, Ophthalmic
                Brimonidine
                 D02076  Brimonidine tartrate (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D02076  Brimonidine tartrate (JAN/USAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00442  Brimonidine
                  D02076  Brimonidine tartrate
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG00442  Brimonidine
                D02076  Brimonidine tartrate
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D02076  Brimonidine tartrate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA2
                 D02076  Brimonidine tartrate (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02076
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02076
            Rx-to-OTC switch list in the USA [br08315.html]
             D02076
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00442  Brimonidine
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG00442  Brimonidine
DBLINKS     CAS: 79570-19-7
            PubChem: 7849138
            ChEBI: 51157
            LigandBox: D02076
ATOM        27
            1   O6a O    21.8870  -16.5436
            2   C6a C    23.0994  -15.8436
            3   C1c C    24.3119  -16.5436
            4   C1c C    25.5244  -15.8436
            5   C6a C    26.7368  -16.5436
            6   O6a O    27.9492  -15.8436
            7   O6a O    23.1003  -14.4436
            8   O6a O    26.7404  -17.9435
            9   O1a O    24.3119  -17.9435
            10  O1a O    25.5244  -14.4436
            11  C8x C     9.7300  -16.3100
            12  C8x C     9.7300  -17.7100
            13  N5x N    10.9424  -18.4100
            14  C8y C    12.1549  -17.7100
            15  C8y C    12.1549  -16.3100
            16  N5x N    10.9424  -15.6100
            17  C8x C    13.3673  -18.4100
            18  C8x C    14.5797  -17.7100
            19  C8y C    14.5797  -16.3100
            20  C8y C    13.3673  -15.6100
            21  N2x N    17.0046  -17.7100
            22  C2y C    17.0046  -16.3100
            23  N1b N    15.7922  -15.6100
            24  C1x C    18.3361  -18.1426
            25  C1x C    19.1590  -17.0100
            26  N1x N    18.3361  -15.8774
            27  X   Br   13.3673  -14.2100
BOND        28
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     2   7 2
            7     5   8 2
            8     3   9 1 #Up
            9     4  10 1 #Up
            10   11  12 2
            11   12  13 1
            12   13  14 2
            13   14  15 1
            14   15  16 2
            15   11  16 1
            16   14  17 1
            17   17  18 2
            18   18  19 1
            19   19  20 2
            20   15  20 1
            21   21  22 2
            22   22  23 1
            23   19  23 1
            24   21  24 1
            25   24  25 1
            26   25  26 1
            27   22  26 1
            28   20  27 1
///
